Home A Different Class of ADT Control CV Risk Economic Burden of CVD Events Disease-Related Symptoms Delay Disease Progression Patient Satisfaction Support & Resources Dosing & Administration Firmagon Licence Prescribing Information

DEGARELIX FERRING dosing and administration

Scroll down to see our summary of top tips video.

Learn More...

INITIATION DOSE

240 mg

First month of treatment

240 mg adminsitered as TWO deep subcutaneous injections of 120 mg each¹
(NB. 3 x 80mg injections are not equivalent)

MAINTENANCE DOSE

80 mg

Monthly administration from second month onwards

Administered as ONE deep subcutaneous injection²

Reconstitution and administration video

Reconstitution and Administration Video Including Top Tips by Leanne McCourt

‍

Learn how to best administer a Degarelix Ferring injection by watching our instructional video with Leanne McCourt, Macmillan Urology Nurse Specialist based in Craigavon Area Hospital, Northern Ireland. This quick demonstration illustrates the precise technique for administering a deep subcutaneous injection into the abdomen. Watch the video now for a comprehensive understanding of the dosing and administration process.

Summary of Top Tips from Leanne

1. Do not reconstitute until ready to administer
2. Swirl don’t shake during reconstitution
3. Administer Firmagon immediately after reconstitution
4. Don’t prime your needle

5. Give via a deep subcutaneous injection
6. Pinch the abdominal skin and vary your site
7. Avoid sites exposed to friction
8. Insert needle in a 45 to 90 degree angle

9. Slowly administer over 30 seconds
10. Following administration hold the needle in place for a further 30 seconds and remove slowly
11. Give the patient self care advice i.e. not to rub or scratch the area and use a cold compress

Dosing and administration video

An educational video featuring Paula Allchorne, Urology Lead Nurse at Bart’s Health Hospital in London and Sacha Ali, Uro-oncology Nurse Specialist at Homerton University Hospital. Degarelix Ferring is a deep subcutaneous injection administered to the abdominal region. It should be administered at a slow and steady pace over 30 seconds.

Injection sites should be varied and not be in areas where the patient will be exposed to pressure e.g. not close to waistband/ belt. Treatment should be continued after initiation and it should only be administered by a healthcare professional.

The injection site should be kept clean and patients should avoid rubbing the area. If your patient experiences a reaction at the injection site, it can be managed with paracetamol or ibuprofen or cooling methods e.g. ice packs. Please watch this video for more information and guidance.

▲ SECTION NAVIGATION ▲

Initiation Dose

Maintenance Dose

Reconstitution Video

Dosing Video

References

References
1. DEGARELIX FERRING 120mg injection Summary of Product Characteristics. Ferring Pharmaceuticals Ltd. October 2022.Available at: https://www.medicines.org.uk/emc/product/6537. Last accessed: January 2024.
2. DEGARELIX FERRING 80 mg injection Summary of Product Characteristics. Ferring Pharmaceuticals Ltd. October 2022.Available at: https://www.medicines.org.uk/emc/product/6535. Last accessed: January 2024.

Our use of cookies

We use cookies (including third party cookies) to collect data while you use this website in order to make it work, keep it secure and comply with regulations. We’d also like your consent to use cookies so we can provide you with tailored content and advertising and analyse how you and other people use the website.

Select “On” to consent to our use of these cookies and continue to the website, or select “Off” to control which types of cookies we use. You can read more about cookies in our Privacy Policy.

Necessary cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytics cookies

We’d like to set Google Analytics cookies to help us to improve our website by collecting and reporting information on how you use it. The cookies collect information in away that does not directly identify anyone. For more information on how these cookies work, please see our Privacy Policy.